Table 1.
Clinical Characteristics Concerning 29 Patients With Gastrointestinal Talaromycosis.
| Characteristics | Patients (n = 29) |
|---|---|
| Area of report | |
| China | 27 (27/29, 93.10%) |
| India | 2 (2/29, 6.90%) |
| Age at diagnosis (years) (median, IQR) | 38 (32, 50.25) |
| Male | 25 (25/29, 86.21%) |
| Medical History | 25 (25/29. 86.21%) |
| AIDS | 19 (19/29, 65.52%) |
| TB | 3 (3/29, 10.34%) |
| Syphilis | 2 (2/29, 6.90%) |
| Renal transplant | 1 (1/29, 3.45%) |
| SLE | 1 (1/29, 3.45%) |
| Waldenstrom macroglobulinemia, ITP, PBC | 1 (1/29, 3.45%) |
| Autoimmune haemolytic anaemia | 1 (1/29, 3.45%) |
| STAT3 mutation | 1 (1/29, 3.45%) |
| HBV carriers | 1 (1/29, 3.45%) |
| Disease course (months) (median, IQR)a | 1.5 (0.5, 3) |
| Anemiaa | 25 (25/27, 92.59%) |
| Intestinal complications | 9 (9/29,31.03%) |
| Obstruction | 3 (3/29, 10.34%) |
| Perforation | 1 (1/29, 3.45%) |
| Obstruction & Perforation | 1 (1/29, 3.45%) |
| Gastrointestinal bleeding | 4 (4/29, 13.79%) |
| Site(s) of positive culture/histology | |
| Intestine | 27 (27/29, 93.10%) |
| Omentum majus | 1 (1/29, 3.45%) |
| Blood | 9 (9/29, 31.03%) |
| Skin | 4 (4/29, 13.79%) |
| Marrow | 6 (6/29, 20.69%) |
| llymph nodes | 4 (4/29, 13.79%) |
| Endoscopya | |
| Erosion /ulceration | 24 (24/27, 88.89%) |
| Hemorrhage | 4 (4/27, 14.81%) |
| Abdomen CTb | |
| Lymphadenopathy | 7 (7/12, 58.33% ) |
| Bowel-wall thickening | 6 (6/12, 50.00% ) |
| Intestinal obstruction | 3 (3/12, 25.00% ) |
| Hepatomegaly/Splenomegaly | 3 (3/12, 25.00% ) |
| Edematous intestine | 2 (2/12, 16.67% ) |
| Treatment | |
| Antifungal treatment | 23 (23/29, 79.31%) |
| Surgery | 6(6/29, 20.69%) |
| None | 2(2/29, 6.90%) |
| Outcome | |
| Survival | 23 (23/29, 79.31%) |
| Died | 5 (5/29, 17.24%) |
| Died of unknown reasons | 1 (1/29, 3.45%) |
AIDS, acquired immunodeficiency syndrome; CT, computed tomography; ITP, idiopathic thrombocytopenic purpura; PBC, primary biliary cirrhosis; PR, present report; TB, tuberculosis.
a27 caces provided haemoglobin values, endoscopic findings and disease course; b12 caces provided abdomen CT descriptions.